SCHEMBL24726826

SCHEMBL24726826

C=C[C@@H](O)C(C)(C)CCCCC

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.34
PTGS1 P23219 1/20 0.34
PPARG P37231 1/20 0.34
OPRK1 P41145 1/20 0.34
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
FDPS P14324 6/20 0.32
GGPS1 O95749 4/20 0.32
LMNA P02545 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CACNA2D1 P54289 1/20 0.32
CACNB2 Q08289 1/20 0.32
CACNA1C Q13936 1/20 0.32
CYP3A4 P08684 1/20 0.32
FAAH O00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24059962 0.83 GGPS1 (0.36) TSHRSMN1; SMN2FDPSGGPS1LMNA
SCHEMBL11481499 0.79 ALDH1A1 (0.31) ALDH1A1
SCHEMBL15570719 0.76 ABCG2 (0.33) ABCG2PTGS1PPARGOPRK1TSHR
SCHEMBL156984 0.75 SMN1; SMN2 (0.41) TSHRSMN1; SMN2FDPSGGPS1LMNA
SCHEMBL28194942 0.74 LMNA (0.40) TSHRFDPSGGPS1LMNAMEN1
SCHEMBL593280 0.74 LMNA (0.40) TSHRFDPSGGPS1LMNAMEN1
SCHEMBL11861395 0.74 LMNA (0.40) TSHRFDPSGGPS1LMNAMEN1
SCHEMBL1659096 0.73 SMN1; SMN2 (0.39) TSHRSMN1; SMN2FDPSGGPS1LMNA
SCHEMBL12514661 0.73 LMNA (0.43) TSHRSMN1; SMN2FDPSGGPS1LMNA
SCHEMBL158353 0.73 LMNA (0.43) TSHRSMN1; SMN2FDPSGGPS1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220281797-A1 KEY INTERMEDIATE FOR SYNTHESIS OF PROSTAGLANDIN COMPOUND AND PREPARATION METHOD THEREOF SHENZHEN CATALYS TECHNOLOGY CO., LTD (CN) 2022-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220281797-A1 KEY INTERMEDIATE FOR SYNTHESIS OF PROSTAGLANDIN COMPOUND AND PREPARATION METHOD THEREOF PTGES, PTGIS, PTGES2 ABCG2 1183/4885PTGS1 4/4885PPARG 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.